FEDERAL POLICY

The AIDS Institute Urges: Vote "NO" on the American Health Care Act

The AIDS Institute sent a letter to The House Ways and Means and Energy and Commerce Committees, urging them to vote "NO" on the recently introduced American Health Care Act.

Read the full letter here.

Comments Re: RIN 0938-AT14 Patient Protection and Affordable Care Act; Market Stabilization

The AIDS Institute submitted comments to the Department of Health and Human Services (HHS) on the Patient Protection and Affordable Care Act; Market Stabilization proposed rule.

Read the full comments here.

Letter to Senate HELP Committee: Concerns on ACA Repeal for People with HIV, Hepatitis, and other Chronic & Serious Conditions

"While the current law is not perfect, the ACA has provided health care coverage to more than 20 million Americans, including tens of thousands with HIV and hepatitis.

The AIDS Institute urges Senate to Vote “NO” on ACA Repeal Budget Resolution

Up to 30 million Americans, including tens of thousands with HIV, rely on the Affordable Care Act (ACA) for health care coverage. We recognize that the law could be improved. But we cannot afford to go backwards by eliminating the life-saving care it provides.

Milliman Medicare Part D Rx Pricing Report

On November 4, 2016, Milliman, Inc. released a report examining the Medicare Part D program and how list prices and rebates for medications impact costs borne by patients, plans, pharmaceutical manufacturers, and the federal government.

View the full report here.

I Am Essential Coalition comments on HHS NBPP 2018 Proposed Rule

We, the 153 undersigned patient and community organizations representing millions of patients and their families, are pleased to submit comments on the proposed rule, Notice of Benefit and Payment Parameters for 2018 (NBPP) (81 FR 61455, Sep. 6, 2016). Our comments reflect the experiences beneficiaries we represent have encountered while shopping for and utilizing the Qualified Health Plans (QHPs) over the past three years.

The AIDS Institute Comments on Arizona Medicaid Changes to Hepatitis C Prior Authorization Requirements

The AIDS Institute submitted comments on Wednesday, September 28, 2016 in response to Arizona Medicaid's proposed changes to their hepatitis C prior authorization policy. The biggest proposed changes included moving from an F score of F3 to F2 and loosening substance use remission restrictions from 6 months to 3 months. Our comments applauded them for taking steps in the right direction, but explained that there is no medical reason to have restrictions in those areas.

I Am Essential Coalition comments on HHS Notice of Benefit and Payment Parameters for 2018 Proposed Rule

The "I Am Essential" coalition, representing hundreds of patient groups and their allies, has prepared comments on the U.S.

TAI submits comments to the DNC and RNC on the 2016 party platforms

Below are The AIDS Institute's written comments on the 2016 party platforms for the Democratic and Republican National Committees 

The AIDS Institute Submits Comments on HHS Listening Session on PrEP

The AIDS Institute presented and offered written testimony to a speical HHS listening session on PrEP. Below are our written comments. 

Syndicate content